113 related articles for article (PubMed ID: 6181486)
1. Preference of the early murine immune response for polymorphic determinants on human lymphoid-leukemia cells and the potential use of monoclonal antibodies to these determinants in leukemia-typing panel.
Maclean GD; Mosmann TR; Akabutu JJ; Longenecker BM
Oncodev Biol Med; 1982; 3(2-3):223-32. PubMed ID: 6181486
[TBL] [Abstract][Full Text] [Related]
2. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of HLA-DR and DR-linked determinants on human leukemias and lymphoid cells.
Newman RA; Delia D; Greaves MF; Navarrete C; Fainboim L; Festenstein H
Eur J Immunol; 1983 Feb; 13(2):172-6. PubMed ID: 6187581
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas.
Krajewski AS; Guy K; Dewar AE; Cossar D
J Pathol; 1985 Feb; 145(2):185-94. PubMed ID: 2579225
[TBL] [Abstract][Full Text] [Related]
5. HLA typing of leukemic cells and lymphoblastoid cell lines: effects of non-HLA antibodies in common typing sera.
DuBois D; Specian TL; Pollack MS
Prog Clin Biol Res; 1977; 16():115-28. PubMed ID: 269454
[TBL] [Abstract][Full Text] [Related]
6. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactions between mouse Ia and human HLA-D/DR antigens analyzed with monoclonal alloantibodies.
Pierres M; Rebouah JP; Kourilsky FM; Dosseto M; Mercier P; Mawas C; Malissen B
J Immunol; 1981 Jun; 126(6):2424-9. PubMed ID: 6785353
[TBL] [Abstract][Full Text] [Related]
8. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
9. Serological detection of B-cell ("Ia-like") antigens in serum of normal donor and in some sera of leukaemic patients.
Koubek K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):408-15. PubMed ID: 6182060
[TBL] [Abstract][Full Text] [Related]
10. Sharing of Ia antigens between species. IV. Interspecies cross-reactivity of monoclonal antibodies directed against polymorphic mouse Ia determinants.
Lunney JK; Osborne BA; Sharrow SO; Devaux C; Pierres M; Sachs DH
J Immunol; 1983 Jun; 130(6):2786-93. PubMed ID: 6406596
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodies.
Mann DL; Haynes BF; Thomas C; Cole D; Fauci AS; Poplack DG
J Natl Cancer Inst; 1983 Jul; 71(1):11-7. PubMed ID: 6602900
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of monoclonal antibodies reactive with porcine PBL.
Pescovitz MD; Lunney JK; Sachs DH
J Immunol; 1984 Jul; 133(1):368-75. PubMed ID: 6609988
[TBL] [Abstract][Full Text] [Related]
13. Identification of normal and transformed lymphocyte subsets of nonhuman primates with monoclonal antibodies to human lymphocytes.
Neubauer RH; Briggs CJ; Noer KB; Rabin H
J Immunol; 1983 Mar; 130(3):1323-9. PubMed ID: 6296233
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of murine monoclonal antibodies against HLA Class II molecules.
Malavasi F; Milanese C; Fabbi M; Richiardi P; Caligaris-Cappio F; Ferrero E; Roggero S; Dellabona P; Ceppellini R
Diagn Immunol; 1984; 2(1):53-62. PubMed ID: 6209059
[TBL] [Abstract][Full Text] [Related]
16. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
[TBL] [Abstract][Full Text] [Related]
17. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
18. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
[TBL] [Abstract][Full Text] [Related]
19. [A new monoclonal antibody produced against a human leukemia which recognizes class II HLA antigens].
Ruiz-Cabello F; González M; López MA; Cabrera A; San Miguel J; Garrido F
Sangre (Barc); 1985; 30(2):190-6. PubMed ID: 3859940
[No Abstract] [Full Text] [Related]
20. Antigenic characterization of a T-CLL with heteroantisera and monoclonal antibodies: evidence for the T cell lineage of an Ia-positive, Fc-IgG--positive, suppressor-cell subpopulation.
Strong DM; Pandolfi F; Slease RB; Budd JE; Woody JN
J Immunol; 1981 Jun; 126(6):2205-8. PubMed ID: 6453158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
